Colorectal Cancer Screening

Who should be screened for Colorectal Cancer?


  At Smilow, we follow slightly modified United States Preventive Services Task Force recommendations for Colorectal Cancer Screening (recent update November 2, 2015, pending approval)




•         Adults, beginning at age 50 years and continuing until age 75 years
•         Younger Adults (before age 50) who have a family history of colorectal cancer or polyps

 

What tests are available through the Smilow Screening and Prevention Program?

 
  • Colonoscopy
Examination of the inside of the colon using a colonoscope, inserted into the rectum.
A colonoscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a tool to remove tissue to be checked under a microscope for signs of disease.
Colonoscopy is not only an effective early detection tool, but it also is used to remove small growths or polyps before they have the chance to become a problem. 
Frequency: For those with family history of colorectal cancer, it is recommended that they undergo a colonoscopy every 5 years. Once every 10 years for most people. 


  • FIT or high-sensitivity gFOBT
Patients who require an alternative to colonoscopy may perform a FIT test once a year.  
This is a test that can be done at home to check stool (solid waste) for blood that can only be seen with a microscope.   It is important to know that a positive FIT test will require that the patient then undergo a colonoscopy to determine if a cancer is present.   
Frequency: Every year.


CHOOSE ONE!  

Colon Cancer Screening can save lives.  Although there is somewhat greater benefit associated with colonoscopy, yearly FIT or gFOBT is also an effective colorectal cancer screening tool. Choosing either of the available screening tests is better than no test!
Contact Us
Phone/Teléfono de contacto: 203.200.3030

Email/Correo electrónico de contacto: screening@ynhh.org

Calendar of Events

Smilow Cancer Hospital Screening Summit 2016: Colorectal

Smilow Cancer Hospital Screening Summit 2016: Colorectal

Xavier Llor, MD, PhD

Associate Professor of Medicine (Digestive Diseases)

Medical Director, Colorectal Cancer Prevention Program

Co-Director, Cancer Genetics and Prevention Program